Variable | Fracture no. (n = 323) | Crude* | Adjusted† | ||||
---|---|---|---|---|---|---|---|
HR | (95%CI) | p-value | HR | (95%CI) | p-value | ||
TCM use | |||||||
No | 193 | 1.00 | reference | 1.00 | reference | ||
Yes | 130 | 0.50 | (0.4–0.63) | <.0001 | 0.47 | (0.37–0.59) | <.0001 |
Gender | |||||||
Female | 266 | 1.00 | reference | 1.00 | reference | ||
Male | 57 | 0.78 | (0.59–1.04) | 0.0939 | 0.58 | (0.43–0.79) | 0.0004 |
Age group, year | |||||||
< 65 | 107 | 1.00 | reference | 1.00 | reference | ||
≥ 65 | 216 | 2.28 | (1.81–2.87) | <.0001 | 2.62 | (2.03–3.39) | <.0001 |
Urbanization level | |||||||
1 (highest) | 73 | 1.00 | reference | 1.00 | reference | ||
2 | 94 | 1.28 | (0.94–1.73) | 0.1173 | 1.24 | (0.91–1.69) | 0.1665 |
3 | 52 | 1.46 | (1.02–2.08) | 0.0372 | 1.43 | (0.99–2.05) | 0.0534 |
4 (lowest) | 104 | 1.54 | (1.14–2.07) | 0.0049 | 1.31 | (0.97–1.77) | 0.0824 |
Baseline comorbidity | |||||||
Alcohol-related disease (Yes vs. No) | 4 | 5.20 | (1.94–13.96) | 0.0011 | 4.38 | (1.6–12.02) | 0.0041 |
Cancer (Yes vs. No) | 9 | 0.83 | (0.43–1.61) | 0.5758 | 0.70 | (0.36–1.37) | 0.2979 |
Cardiovascular disease (Yes vs. No) | 139 | 1.38 | (1.1–1.71) | 0.0046 | 1.07 | (0.83–1.38) | 0.5856 |
Chronic kidney disease (Yes vs. No) | 9 | 1.22 | (0.63–2.36) | 0.5608 | 1.05 | (0.53–2.07) | 0.8909 |
Chronic obstructive pulmonary (Yes vs. No)disease | 92 | 1.25 | (0.98–1.59) | 0.0759 | 1.20 | (0.93–1.54) | 0.1688 |
Diabetes mellitus (Yes vs. No) | 87 | 1.20 | (0.94–1.54) | 0.1442 | 1.11 | (0.85–1.44) | 0.4518 |
Dementia (Yes vs. No) | 6 | 1.62 | (0.72–3.64) | 0.2432 | 1.00 | (0.43–2.29) | 0.9909 |
Depression (Yes vs. No) | 25 | 1.41 | (0.94–2.12) | 0.0972 | 1.62 | (1.05–2.5) | 0.0285 |
Hyperlipidemia (Yes vs. No) | 62 | 0.79 | (0.6–1.04) | 0.0922 | 0.73 | (0.54–0.98) | 0.0352 |
Hypertension (Yes vs. No) | 186 | 1.28 | (1.03–1.59) | 0.0292 | 0.92 | (0.72–1.19) | 0.5362 |
Parkinson’s disease (Yes vs. No) | 5 | 1.25 | (0.52–3.02) | 0.6248 | 0.92 | (0.37–2.27) | 0.8498 |